<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d1 20130915//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Cell Sci</journal-id><journal-id journal-id-type="iso-abbrev">J. Cell. Sci</journal-id><journal-id journal-id-type="publisher-id">JCS</journal-id><journal-id journal-id-type="hwp">joces</journal-id><journal-title-group><journal-title>Journal of Cell Science</journal-title></journal-title-group><issn pub-type="ppub">0021-9533</issn><issn pub-type="epub">1477-9137</issn><publisher><publisher-name>The Company of Biologists Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4732286</article-id><article-id pub-id-type="pmid">26598557</article-id><article-id pub-id-type="doi">10.1242/jcs.177675</article-id><article-id pub-id-type="publisher-id">JCS177675</article-id><article-categories><subj-group subj-group-type="heading"><subject>Short Report</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Wnt/β-catenin and LIF–Stat3 signaling pathways converge on Sp5 to promote mouse embryonic stem cell self-renewal </plain></SENT>
</text></SecTag></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ye</surname><given-names>Shoudong</given-names></name><xref ref-type="aff" rid="af1">1</xref><xref ref-type="aff" rid="af2">2</xref><xref ref-type="author-notes" rid="AN1">*</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Dongming</given-names></name><xref ref-type="aff" rid="af1">1</xref><xref ref-type="author-notes" rid="AN1">*</xref></contrib><contrib contrib-type="author"><name><surname>Cheng</surname><given-names>Fei</given-names></name><xref ref-type="aff" rid="af1">1</xref><xref ref-type="author-notes" rid="AN1">*</xref></contrib><contrib contrib-type="author"><name><surname>Wilson</surname><given-names>Daniel</given-names></name><xref ref-type="aff" rid="af2">2</xref></contrib><contrib contrib-type="author"><name><surname>Mackay</surname><given-names>Jeffrey</given-names></name><xref ref-type="aff" rid="af2">2</xref></contrib><contrib contrib-type="author"><name><surname>He</surname><given-names>Kan</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ban</surname><given-names>Qian</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Lv</surname><given-names>Feng</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Saifei</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Dahai</given-names></name><xref ref-type="aff" rid="af1">1</xref><xref ref-type="corresp" rid="cor1">‡</xref></contrib><contrib contrib-type="author"><name><surname>Ying</surname><given-names>Qi-Long</given-names></name><xref ref-type="aff" rid="af2">2</xref><xref ref-type="corresp" rid="cor1">‡</xref></contrib></contrib-group><aff id="af1"><label>1</label><institution>Center for Stem Cell and Translational Medicine, School of Life Sciences, Anhui University</institution>, <addr-line>Hefei 230601</addr-line>, <country>People's Republic of China</country></aff><aff id="af2"><label>2</label><institution>Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC</institution>, <addr-line>Department of Stem Cell Biology and Regenerative Medicine</addr-line>, <institution>Keck School of Medicine, University of Southern California</institution>, <addr-line>Los Angeles, CA 90033</addr-line>, <country>USA</country></aff><author-notes><fn id="AN1" fn-type="equal"><label>*</label><p><text><SENT sid="1" pm="."><plain>These authors contributed equally to this work </plain></SENT>
</text></p></fn><corresp id="cor1"><label>‡</label>Authors for correspondence (<email>seansean2015@ahu.edu.cn</email>; <email>qying@med.usc.edu</email>)</corresp></author-notes><pub-date pub-type="ppub"><day>15</day><month>1</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>15</day><month>1</month><year>2016</year></pub-date><volume>129</volume><issue>2</issue><fpage>269</fpage><lpage>276</lpage><history><date date-type="received"><day>15</day><month>7</month><year>2015</year></date><date date-type="accepted"><day>18</day><month>11</month><year>2015</year></date></history><permissions><copyright-statement>© 2016. Published by The Company of Biologists Ltd</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<uri xlink:href="http://creativecommons.org/licenses/by/3.0">http://creativecommons.org/licenses/by/3.0</uri>), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.</license-p></license><?release-delay 0|0?></permissions><self-uri content-type="pdf" xlink:href="joces-129-177675.pdf"/><abstract><title><text><SENT sid="2" pm="."><plain>ABSTRACT </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="3" pm="."><plain>Activation of leukemia inhibitor factor (LIF)–Stat3 or Wnt/β-catenin signaling promotes mouse embryonic stem cell (mESC) self-renewal. </plain></SENT>
<SENT sid="4" pm="."><plain>A myriad of downstream targets have been identified in the individual signal pathways, but their common targets remain largely elusive. </plain></SENT>
<SENT sid="5" pm="."><plain>In this study, we found that the LIF–Stat3 and Wnt/β-catenin signaling pathways converge on Sp5 to promote mESC self-renewal. </plain></SENT>
<SENT sid="6" pm="."><plain>Forced Sp5 expression can reproduce partial effects of Wnt/β-catenin signaling but mimics most features of LIF–Stat3 signaling to maintain undifferentiated mESCs. </plain></SENT>
<SENT sid="7" pm="."><plain>Moreover, Sp5 is able to convert mouse epiblast stem cells into a naïve pluripotent state. </plain></SENT>
<SENT sid="8" pm="."><plain>Thus, Sp5 is an important component of the regulatory network governing mESC naïve pluripotency. </plain></SENT>
</text></SecTag></p></abstract><abstract abstract-type="precis"><p><SecTag type="ABS"><text><SENT sid="9" pm="."><plain>Summary: This study reveals a new function of Sp5 in mouse embryonic stem cell (ESC) self-renewal mediated by CHIR99021 and LIF, and reprogramming of EpiSCs into naїve ESCs. </plain></SENT>
</text></SecTag></p></abstract><SecTag type="KEYWORD"><kwd-group><title>KEY WORDS</title><kwd>Embryonic stem cell</kwd><kwd>Self-renewal</kwd><kwd>β-catenin</kwd><kwd>Stat3</kwd><kwd>Sp5</kwd></kwd-group></SecTag><funding-group specific-use="FundRef"><award-group><funding-source><institution-wrap><institution>California Institute for Regenerative Medicine (CIRM) New Faculty Award II</institution></institution-wrap></funding-source><award-id>RN2-00938</award-id></award-group></funding-group><funding-group specific-use="FundRef"><award-group><funding-source><institution-wrap><institution>CIRM Scientific Excellence through Exploration and Development (SEED) Grant</institution></institution-wrap></funding-source><award-id>RS1-00327</award-id></award-group></funding-group><funding-group specific-use="FundRef"><award-group><funding-source><institution-wrap><institution>211 Scientific Research Startup Fund of Anhui University</institution></institution-wrap></funding-source><award-id>10117700027</award-id><award-id>32030081</award-id><award-id>J10117700060</award-id></award-group></funding-group><funding-group specific-use="FundRef"><award-group><funding-source><institution-wrap><institution>the Student Research Training Program of Anhui University</institution></institution-wrap></funding-source><award-id>J10118515486</award-id></award-group></funding-group><funding-group specific-use="FundRef"><award-group><funding-source><institution-wrap><institution>Natural Science Foundation of Anhui province and China</institution></institution-wrap></funding-source><award-id>1508085SQC204</award-id><award-id>1508085MH189</award-id><award-id>31501191</award-id></award-group></funding-group></article-meta></front><body><SecTag type="INTRO"><sec sec-type="intro" id="s1"><title><text><SENT sid="10" pm="."><plain>INTRODUCTION </plain></SENT>
</text></title><p><text><SENT sid="11" pm="."><plain>Mouse embryonic stem cells (mESCs) are pluripotent cell lines derived from pre-implantation embryos (Evans and Kaufman, 1981; Martin, 1981). </plain></SENT>
<SENT sid="12" pm="."><plain>They can be expanded in serum-containing medium with LIF, or serum-free N2B27 medium with 2i (hereafter N2B27/2i, see below) in vitro while retaining the capacity for multilineage differentiation (Smith, 2001; Williams et al., 1988; Ying et al., 2008). </plain></SENT>
<SENT sid="13" pm="."><plain>LIF binds to the LIF-receptor–gp130 heterodimer (gp130 is also known as IL6ST), leading to phosphorylation of Stat3 by JAK. </plain></SENT>
<SENT sid="14" pm="."><plain>Activated Stat3 then translocates into the nucleus and binds DNA (Niwa et al., 1998). </plain></SENT>
<SENT sid="15" pm="."><plain>Stat3 plays a key role in LIF-mediated mESC self-renewal. </plain></SENT>
<SENT sid="16" pm="."><plain>A chimeric Stat3 protein fused with the ligand-binding domain of the estrogen receptor (Stat3ER) maintains mESCs in an undifferentiated state in the presence of the synthetic ligand 4-hydroxytamoxifen (4-HT or 4-OHT) without LIF (Matsuda et al., 1999). </plain></SENT>
<SENT sid="17" pm="."><plain>By contrast, overexpressing a dominant-negative mutant of Stat3 in mESCs blocks LIF-induced activation of endogenous Stat3 and causes differentiation (Niwa et al., 1998). </plain></SENT>
<SENT sid="18" pm="."><plain>Furthermore, LIF fails to maintain Stat3-null mESC self-renewal (Ying et al., 2008). </plain></SENT>
<SENT sid="19" pm="."><plain>Many Stat3 targets have been identified recently, such as Klf4, Gbx2, Pim1, Pim3, Pramel7, Myc and Tfcp2l1 (Cartwright et al., 2005; Casanova et al., 2011; Hall et al., 2009; Martello et al., 2013; Tai and Ying, 2013; Ye et al., 2013). </plain></SENT>
<SENT sid="20" pm="."><plain>When overexpressed, these genes can bypass the LIF requirement for mESC maintenance. </plain></SENT>
<SENT sid="21" pm="."><plain>However, knockdown of any single gene does not abolish the self-renewal-promoting effect of LIF–Stat3 signaling, suggesting that LIF–Stat3 signaling triggers multiple downstream targets to promote mESC self-renewal. </plain></SENT>
</text></p><p><text><SENT sid="22" pm="."><plain>2i contains two small molecules: CHIR99021 (CHIR) and PD0325901 (PD03), which inhibit glycogen synthase kinase 3 (GSK3) and mitogen-activated protein kinase (MAPK) kinases (MEK proteins), respectively (Huang et al., 2015; Ye et al., 2014; Ying et al., 2008). </plain></SENT>
<SENT sid="23" pm="."><plain>Inhibiting GSK3 results in the activation of the Wnt/β-catenin signaling pathway. </plain></SENT>
<SENT sid="24" pm="."><plain>Once in the nucleus, β-catenin liberates many Tcf3-repressed pluripotency genes (Wray et al., 2011), such as Esrrb, Nr0b1, Tfcp2l1 and Nanog (Martello et al., 2012). </plain></SENT>
<SENT sid="25" pm="."><plain>It is noteworthy that 2i can sustain Stat3-null mESC self-renewal (Ying et al., 2008), whereas the identity of β-catenin-null mESCs can be maintained in medium containing LIF and PD03 (Lyashenko et al., 2011). </plain></SENT>
<SENT sid="26" pm="."><plain>Taken together, these results suggest CHIR and LIF might share common or cross-compensatory downstream targets in promoting mESC self-renewal. </plain></SENT>
<SENT sid="27" pm="."><plain>Here, we identified Sp5 as one of common targets of CHIR and LIF, and revealed its new function in promoting mESC self-renewal and reprogramming. </plain></SENT>
</text></p></sec></SecTag><SecTag type="RESULTS,DISCUSS"><sec id="s2"><title><text><SENT sid="28" pm="."><plain>RESULTS AND DISCUSSION </plain></SENT>
</text></title><sec id="s2a"><title><text><SENT sid="29" pm="."><plain>Identification of downstream targets of CHIR and LIF in mESCs </plain></SENT>
</text></title><p><text><SENT sid="30" pm="."><plain>To screen the possible shared targets of the Wnt/β-catenin and LIF–Stat3 signaling pathways, we performed a DNA microarray analysis in mESCs treated with or without CHIR (GEO Number: GSE50393). </plain></SENT>
<SENT sid="31" pm="."><plain>We then looked for genes that were upregulated by 1.5 times or greater by CHIR treatment or by Stat3 stimulation (Bourillot et al., 2009). </plain></SENT>
<SENT sid="32" pm="."><plain>From this comparison, two common targets emerged: Trh and Sp5 (Fig. 1A). </plain></SENT>
<SENT sid="33" pm="."><plain>Trh, or thyrotropin-releasing hormone, is a secretory protein. </plain></SENT>
<SENT sid="34" pm="."><plain>Sp5 (trans-acting transcription factor 5) belongs to the Sp1 transcription factor family (el-Baradi and Pieler, 1991; Wimmer et al., 1993) and harbors three zinc fingers that are similar to those found in members of the KLF gene family (Suske et al., 2005; Treichel et al., 2001). </plain></SENT>
<SENT sid="35" pm="."><plain>KLF family members, such as Klf2, Klf4 and Klf5, play an important role in maintaining mESC self-renewal (Ema et al., 2008; Hall et al., 2009; Jiang et al., 2008; Qiu et al., 2015). </plain></SENT>
<SENT sid="36" pm="."><plain>We thus chose Sp5 as our candidate gene. </plain></SENT>
<SENT sid="37" pm="."><plain>Quantitative real-time PCR (qRT-PCR) was used to confirm that both CHIR and LIF treatments could induce the expression of Sp5 (Fig. 1B). Socs3, a direct target of LIF–Stat3 signaling, was used as a positive control and showed substantial induction upon LIF stimulation (Fig. 1B) (Niwa et al., 2009). Fig. 1.Overexpressing Sp5 partially mimics the effect of CHIR in medium with 2i. (A) Flow chart showing the method used to identify candidate genes downstream of CHIR and Stat3. </plain></SENT>
<SENT sid="38" pm="."><plain>(B) qRT-PCR analysis of Socs3 and Sp5 expression induced by CHIR, PD03 and 2i (left), or LIF (right) for 12 h. </plain></SENT>
<SENT sid="39" pm="."><plain>Data represent mean±s.d. of three biological replicates. **P&lt;0.01 versus NT. </plain></SENT>
<SENT sid="40" pm="."><plain>NT, no treatment. </plain></SENT>
<SENT sid="41" pm="."><plain>(C) FLAG-tagged Sp5 was introduced into 46C mESCs and the protein level of FLAG-tagged SP5 was determined by western blotting. α-tubulin is used as a loading control. </plain></SENT>
<SENT sid="42" pm="."><plain>(D,E) Alkaline phosphatase staining images of PB-Sp5 mESCs cultured in N2B27 medium with PD03 for the indicated number of passages (P). </plain></SENT>
<SENT sid="43" pm="."><plain>Scale bars: 100 μm. </plain></SENT>
<SENT sid="44" pm="."><plain>(F–H) qRT-PCR analysis of the indicated gene expression after treatment with CHIR for the indicated time in 46C mESCs, CTNNB1-KO (β-catenin knockout) and Tcf3-KO mESCs. </plain></SENT>
<SENT sid="45" pm="."><plain>CHX, cycloheximide treatment. </plain></SENT>
<SENT sid="46" pm="."><plain>Data represent mean±s.d. of three biological replicates. **P&lt;0.01 versus 0 h CHIR. </plain></SENT>
</text></p></sec><sec id="s2b"><title><text><SENT sid="47" pm="."><plain>Overexpression of Sp5 promotes mESC self-renewal in the absence of CHIR </plain></SENT>
</text></title><p><text><SENT sid="48" pm="."><plain>We then investigated the function of Sp5 in CHIR- and LIF-mediated self-renewal in mESCs. </plain></SENT>
<SENT sid="49" pm="."><plain>We generated an mESC line that overexpressed FLAG-tagged Sp5 using a PiggyBac vector (PB-Sp5) in which Sp5 expression was efficiently enhanced (Fig. 1C). </plain></SENT>
<SENT sid="50" pm="."><plain>Empty vector (PB) and PB-Sp5 mESCs grew robustly in N2B27/2i, and in serum-containing medium with LIF. </plain></SENT>
<SENT sid="51" pm="."><plain>We then withdrew CHIR to test the ability of Sp5 to replace the function of CHIR in N2B27/2i. </plain></SENT>
<SENT sid="52" pm="."><plain>Before passaging, PB-Sp5 mESCs maintained an undifferentiated state, whereas cells containing only PB began to die (Fig. 1D,E). </plain></SENT>
<SENT sid="53" pm="."><plain>Moreover, PB-Sp5 mESCs could be split for three more passages, but then also collapsed and lost alkaline phosphatase activity (Fig. 1D,E). </plain></SENT>
<SENT sid="54" pm="."><plain>Therefore, overexpressing Sp5 supports short-term mESC self-renewal when combined with PD03, indicating that Sp5 partially reproduces the effect of CHIR in 2i. </plain></SENT>
</text></p><p><text><SENT sid="55" pm="."><plain>Sp5 is known to be a downstream target of the Wnt/β-catenin signaling pathway during vertebrate development and in cancer cells (Hoverter et al., 2012; Waaler et al., 2011; Weidinger et al., 2005). </plain></SENT>
<SENT sid="56" pm="."><plain>To determine whether Sp5 is regulated through the Wnt/β-catenin signaling pathway in mESCs, we examined the expression of Sp5 in 46C ESCs after CHIR treatment for 2 h. Sp5 exhibited signiﬁcantly increased expression in response to CHIR, even in the presence of the protein synthesis inhibitor cycloheximide (Fig. 1F). </plain></SENT>
<SENT sid="57" pm="."><plain>Furthermore, CHIR failed to induce Sp5 expression in β-catenin-null ESCs (Fig. 1G), indicating that Sp5 is a direct target of β-catenin in mESCs. </plain></SENT>
<SENT sid="58" pm="."><plain>Notably, CHIR upregulated Sp5 in the absence of Tcf3 without a change in the expression of other members of the Tcf family, including Lef1, Tcf1 and Tcf4 (Fig. 1H), indicating that β-catenin can induce Sp5 expression through interaction with Tcf factors but not Tcf3. </plain></SENT>
</text></p></sec><sec id="s2c"><title><text><SENT sid="59" pm="."><plain>Overexpression of Sp5 maintains mESC self-renewal in the absence of LIF </plain></SENT>
</text></title><p><text><SENT sid="60" pm="."><plain>To determine the role of Sp5 in LIF–Stat3 signaling, we performed experiments in serum-containing medium without LIF. </plain></SENT>
<SENT sid="61" pm="."><plain>Surprisingly, PB-Sp5 mESCs could be continually passaged while retaining typical ESC morphology, positive alkaline phosphatase activity and high expression levels of the pluripotency markers OCT4, NANOG and KLF4, whereas empty vector (PB) control cells differentiated (Fig. 2A,B; Fig. S1A–C). </plain></SENT>
<SENT sid="62" pm="."><plain>The results were validated in OCRG9 mESCs harboring an Oct4–GFP pluripotency reporter (Fig. S1D,E). </plain></SENT>
<SENT sid="63" pm="."><plain>We then tried culturing PB and PB-Sp5 46C ESCs in N2B27 medium with BMP4, which maintains mESC self-renewal when combined with LIF (Ying et al., 2003). </plain></SENT>
<SENT sid="64" pm="."><plain>Similarly, PB-Sp5 mESCs maintained an undifferentiated state, whereas PB cells differentiated rapidly (Fig. 2C,D). </plain></SENT>
<SENT sid="65" pm="."><plain>We found that overexpression of Sp5 led to an upregulation in the level of Nanog, whereas it repressed the expression of the differentiation markers Gata4 and Gata6. </plain></SENT>
<SENT sid="66" pm="."><plain>Both of these markers are typically suppressed by Nanog in mESCs (Fig. 2E) (Chambers et al., 2003). </plain></SENT>
<SENT sid="67" pm="."><plain>These collective results suggest that elevated expression of Sp5 recapitulates the self-renewal-promoting effect of the LIF–Stat3 signaling pathway, probably through induction of Nanog expression. Fig. 2.Forced Sp5 expression promotes mESC self-renewal without LIF addition. (A) Alkaline phosphatase staining of PB and PB-Sp5 mESCs cultured in serum for five passages. </plain></SENT>
<SENT sid="68" pm="."><plain>Scale bar: 100 μm. </plain></SENT>
<SENT sid="69" pm="."><plain>(B) Immunofluorescence staining of PB and PB-Sp5 mESCs cultured in medium with serum for five passages. </plain></SENT>
<SENT sid="70" pm="."><plain>Scale bar: 100 μm. </plain></SENT>
<SENT sid="71" pm="."><plain>Hoechst, Hoechst 33342. </plain></SENT>
<SENT sid="72" pm="."><plain>(C,D) Phase contrast (C) and alkaline phosphatase staining (D) images of PB and PB-Sp5 mESCs cultured in N2B27 medium with BMP4 in the absence or presence of LIF for 8 days. </plain></SENT>
<SENT sid="73" pm="."><plain>Scale bars: 100 μm. </plain></SENT>
<SENT sid="74" pm="."><plain>(E) qRT-PCR analysis of Sp5, Nanog, Gata4 and Gata6 expression in PB and PB-Sp5 46C ESCs cultured in medium with LIF and serum. </plain></SENT>
<SENT sid="75" pm="."><plain>Data represent mean±s.d. of three biological replicates. *P&lt;0.05, **P&lt;0.01 versus PB. </plain></SENT>
<SENT sid="76" pm="."><plain>(F) Diagram showing the Cre-excisable construct used for Sp5 overexpression. </plain></SENT>
<SENT sid="77" pm="."><plain>(G) Phase contrast and GFP images of loxP-Sp5 mESCs after transfection with or without the Cre expression plasmid. </plain></SENT>
<SENT sid="78" pm="."><plain>ESCs were cultured in medium with LIF and serum. </plain></SENT>
<SENT sid="79" pm="."><plain>Scale bar: 100 μm. </plain></SENT>
<SENT sid="80" pm="."><plain>(H) Immunofluorescence staining for the neural marker nestin, the cardiomyocyte marker myosin, and the primitive endoderm marker GATA4 in differentiated cells derived from loxP-Sp5 mESCs in which the Sp5 transgene has been removed by Cre. </plain></SENT>
<SENT sid="81" pm="."><plain>Hoechst 33342 was used for nuclear staining. </plain></SENT>
<SENT sid="82" pm="."><plain>Scale bar: 100 μm. </plain></SENT>
<SENT sid="83" pm="."><plain>(I) qRT-PCR analysis of the indicated gene expression in ESCs and embryoid bodies (EB) derived from cells with an excised Sp5 transgene. </plain></SENT>
<SENT sid="84" pm="."><plain>Pluripotency genes, Oct4 and Nanog; trophoblast marker, Cdx2; ectoderm marker, nestin; mesoderm markers, Mixl1 and Gsc; endoderm makers, Gata4 and Sox17. *P&lt;0.05, **P&lt;0.01 versus ESCs. </plain></SENT>
</text></p><p><text><SENT sid="85" pm="."><plain>To examine whether mESCs maintained by Sp5 overexpression retain pluripotency, we used a loxP-based excisable vector to overexpress Sp5. </plain></SENT>
<SENT sid="86" pm="."><plain>After expansion in the absence of LIF for five passages, the ﬂoxed-Sp5 mESCs were transiently transfected with a Cre expression vector to excise the floxed Sp5 transgene (Fig. 2F). </plain></SENT>
<SENT sid="87" pm="."><plain>After the excision of Sp5 transgene, the GFP transgene was activated, and their maintenance became dependent on LIF (Fig. 2G). </plain></SENT>
<SENT sid="88" pm="."><plain>The revertant cells maintained the ability to differentiate into cells from the three germ layers after forming embryoid bodies (Fig. 2H,I), suggesting that Sp5 overexpressing ESCs retain their pluripotency. </plain></SENT>
</text></p></sec><sec id="s2d"><title><text><SENT sid="89" pm="."><plain>Overexpressing Sp5 sustains Stat3-null ESCs in an undifferentiated state </plain></SENT>
</text></title><p><text><SENT sid="90" pm="."><plain>To determine whether Stat3 is dispensable for Sp5-promoted mESC self-renewal, we overexpressed Sp5 in Stat3-null mESCs and cultured them in serum-containing medium without LIF. </plain></SENT>
<SENT sid="91" pm="."><plain>These transfectants remained undifferentiated, whereas Stat3-null mESCs transfected with an empty vector died or differentiated after two passages (Fig. S2). </plain></SENT>
<SENT sid="92" pm="."><plain>These results suggest that the self-renewal-promoting effect of Sp5 is independent of Stat3. </plain></SENT>
</text></p></sec><sec id="s2e"><title><text><SENT sid="93" pm="."><plain>Sp5 is a direct downstream target of the LIF–Stat3 signaling pathway </plain></SENT>
</text></title><p><text><SENT sid="94" pm="."><plain>LIF mainly activates three intracellular signaling pathways: the JAK–Stat3, PI3K–AKT and MAPK pathways (Hirai et al., 2011). </plain></SENT>
<SENT sid="95" pm="."><plain>To examine whether Sp5 is a direct target of LIF–Stat3 pathway, we tested the responsiveness of Sp5 to the activation of Stat3. </plain></SENT>
<SENT sid="96" pm="."><plain>LIF stimulation for 1 h in 46C mESCs led to an accumulation of phosphorylated STAT3 and acute transcript induction of Socs3 and Sp5 (Fig. 3A,B). </plain></SENT>
<SENT sid="97" pm="."><plain>However, their expression was suppressed by JAK inhibitor (Fig. 3A). </plain></SENT>
<SENT sid="98" pm="."><plain>This phenomenon was also observed in the presence of the protein synthesis inhibitor cycloheximide (Fig. 3A,B). </plain></SENT>
<SENT sid="99" pm="."><plain>A similar expression pattern of Sp5 induction was observed in GY118F and Stat3ER transfectants (Fig. 3C–F). </plain></SENT>
<SENT sid="100" pm="."><plain>GY118F is a mutated chimeric receptor and only triggers JAK–Stat3 signaling in the presence of granulocyte colony stimulating factor (GCSF) (Burdon et al., 1999). </plain></SENT>
<SENT sid="101" pm="."><plain>Stat3ER stimulates Stat3 direct targets by translocating into the nucleus in the presence of 4-HT. </plain></SENT>
<SENT sid="102" pm="."><plain>This process occurs independently of endogenous STAT3, MAPK and AKT (Bourillot et al., 2009; Matsuda et al., 1999). </plain></SENT>
<SENT sid="103" pm="."><plain>Collectively, these data indicate that Sp5 is a direct target of the LIF–Stat3 signaling pathway. </plain></SENT>
<SENT sid="104" pm="."><plain>However, knockdown of Sp5 did not impair the self-renewal-promoting effect of LIF–Stat3 signaling (Fig. S3A,B). </plain></SENT>
<SENT sid="105" pm="."><plain>Interestingly, downregulation of Sp5 significantly induced Pim1 (a Stat3 direct target) expression (Fig. S3A) (Martello et al., 2013), suggesting that the self-renewal-promoting function of Sp5 is redundant with other Stat3 targets in mESCs. Fig. 3.Sp5 is a direct target of Stat3. (A) qRT-PCR analysis of Socs3 and Sp5 expression levels in 46C mESCs deprived of LIF overnight and stimulated with LIF for 1 h in the presence or absence of JAK inhibitor I (JAKi) or cycloheximide (CHX, 50 mg/ml). </plain></SENT>
<SENT sid="106" pm="."><plain>Data represent mean±s.d. of three biological replicates. **P&lt;0.01 vesus 46C NT. </plain></SENT>
<SENT sid="107" pm="."><plain>NT, no treatment. </plain></SENT>
<SENT sid="108" pm="."><plain>(B,C) qRT-PCR analysis of Socs3 and Sp5 in GY118F and Stat3ER transfectants deprived of LIF overnight and stimulated with GCSF or 4-HT for 1 h. </plain></SENT>
<SENT sid="109" pm="."><plain>Data represent mean±s.d. of three biological replicates. **P&lt;0.01 versus NT. </plain></SENT>
<SENT sid="110" pm="."><plain>(D–F) Western blot analysis of total and phosphorylated Stat3 and β-catenin in wild type, and GY118F- and Stat3ER-transfected mESCs. p, phosphorylated protein. </plain></SENT>
<SENT sid="111" pm="."><plain>(G,H) qRT-PCR analysis of Socs3 and Sp5 in β-catenin-null or 46C mESCs treated with LIF or CHIR for 2 h in the presence or absence of JAK inhibitor I. Data represent mean±s.d. of three biological replicates. *P&lt;0.05, **P&lt;0.01 versus NT. </plain></SENT>
</text></p></sec><sec id="s2f"><title><text><SENT sid="113" pm="."><plain>LIF and CHIR upregulates Sp5 expression independently </plain></SENT>
</text></title><p><text><SENT sid="114" pm="."><plain>Given that Sp5 is also a direct target of the Wnt/β-catenin signaling pathway (Dunty et al., 2014; Weidinger et al., 2005), we next wanted to examine whether LIF and CHIR depended on each other to exert their own upregulating effect. </plain></SENT>
<SENT sid="115" pm="."><plain>CHIR strongly induced Sp5 expression in 46C mESCs in the presence of JAK inhibitor whereas LIF failed (Fig. 3G). </plain></SENT>
<SENT sid="116" pm="."><plain>By contrast, LIF stimulated Sp5 expression in the absence of β-catenin, whereas CHIR-mediated induction of Sp5 was dependent on β-catenin (Fig. 3H), indicating that LIF and CHIR induce Sp5 transcription independently of one another. </plain></SENT>
</text></p></sec><sec id="s2g"><title><text><SENT sid="117" pm="."><plain>Sp5 is able to reprogram EpiSCs to a naïve state </plain></SENT>
</text></title><p><text><SENT sid="118" pm="."><plain>Another distinguishing feature of LIF–Stat3 signaling is its ability to convert mouse epiblast stem cells (EpiSCs) into cells with a naïve state of pluripotency (van Oosten et al., 2012; Yang et al., 2010). </plain></SENT>
<SENT sid="119" pm="."><plain>Mouse EpiSCs are isolated from epiblasts of post-implantation mouse embryos and share many features with human ESCs (Brons et al., 2007; Tesar et al., 2007). Stat3 and its multiple targets are expressed highly in mESCs, but are downregulated in EpiSCs. </plain></SENT>
<SENT sid="120" pm="."><plain>Importantly, their overexpression is sufficient to reprogram EpiSC into the mESC state (Guo et al., 2009; Tai and Ying, 2013; Yang et al., 2010). </plain></SENT>
<SENT sid="121" pm="."><plain>To test the role of Sp5 in EpiSC reprogramming, we first differentiated 46C mESCs into EpiSCs (Fig. 4A), but observed no obvious change in Sp5 expression (Fig. 4B). </plain></SENT>
<SENT sid="122" pm="."><plain>We then engineered 46C EpiSCs to overexpress Sp5 (Fig. 4C) and cultured 106 transfectants in medium containing LIF, serum and 2i. </plain></SENT>
<SENT sid="123" pm="."><plain>After 12 days, five ESC-like colonies emerged, whereas empty vector transfectants died or differentiated (Fig. 4D). </plain></SENT>
<SENT sid="124" pm="."><plain>We then picked two colonies and these colonies continuously expanded in medium containing serum and LIF. </plain></SENT>
<SENT sid="125" pm="."><plain>They expressed high levels of the naïve pluripotency markers Nanog, Stella, Nrob1, Klf2 and Rex1, but low levels of the EpiSC-specific markers Fgf5 and Sox17 (Fig. 4E). </plain></SENT>
<SENT sid="126" pm="."><plain>We confirmed this experiment in E3 EpiSCs carrying an Oct4–GFP pluripotency reporter (Greber et al., 2010). </plain></SENT>
<SENT sid="127" pm="."><plain>The Sp5-reprogrammed stem cells were expanded in medium containing serum and LIF over multiple passages, showing undifferentiated morphology and stable expression of the Oct4–GFP reporter (Fig. S4A,B). </plain></SENT>
<SENT sid="128" pm="."><plain>These results imply that forced expression of Sp5 is capable of converting EpiSCs into a naïve pluripotent state. Fig. 4.Forced expression of Sp5 promotes EpiSC reprogramming to naïve pluripotency. (A) Phase contrast and alkaline phosphatase (AP) staining images of 46C mESCs and 46C mESC-derived EpiSCs. </plain></SENT>
<SENT sid="129" pm="."><plain>Scale bar: 100 μm. </plain></SENT>
<SENT sid="130" pm="."><plain>(B) qRT-PCR analysis of expression patterns of Sp5, Oct4, Rex1 and Fgf5 in 46C mESCs and EpiSCs. </plain></SENT>
<SENT sid="131" pm="."><plain>Data represent mean±s.d. of three biological replicates. **P&lt;0.01 versus 46C mESCs. </plain></SENT>
<SENT sid="132" pm="."><plain>(C) Western blot analysis for Sp5 in 46C EpiSCs transfected with vector expressing FLAG-tagged Sp5. </plain></SENT>
<SENT sid="133" pm="."><plain>(D) Phase contrast and alkaline phosphatase staining images of Sp5 EpiSC transfectants and Sp5 EpiSC transfectant-derived induced pluripotent stem cells (iPSCs). </plain></SENT>
<SENT sid="134" pm="."><plain>Scale bar: 100 μm. </plain></SENT>
<SENT sid="135" pm="."><plain>(E) qRT-PCR analysis of Oct4, Nanog, Stella, Nr0b1, Klf2, Rex1, Fgf5 and Sox17 expression in Sp5 EpiSCs and two Sp5 Epi-iPS colonies. </plain></SENT>
<SENT sid="136" pm="."><plain>Data represent mean±s.d. of three biological replicates. **P&lt;0.01 versus Sp5 EpiSCs. </plain></SENT>
<SENT sid="137" pm="."><plain>C1 and C2 are the individual colonies of ESC-like cell. </plain></SENT>
<SENT sid="138" pm="."><plain>Epi-iPS, EpiSC-derived iPSCs. </plain></SENT>
</text></p></sec><sec id="s2h"><title><text><SENT sid="139" pm="."><plain>Conclusions </plain></SENT>
</text></title><p><text><SENT sid="140" pm="."><plain>CHIR and LIF have redundant function in mESC maintenance. </plain></SENT>
<SENT sid="141" pm="."><plain>We demonstrate that Sp5 is a convergent target of the Wnt/β-catenin and LIF–Stat3 signaling pathways. </plain></SENT>
<SENT sid="142" pm="."><plain>In support of this, we present evidence that Sp5 recapitulates features of Wnt/β-catenin and LIF–Stat3 signaling in promoting mESC self-renewal. </plain></SENT>
<SENT sid="143" pm="."><plain>Furthermore, overexpression of Sp5 is able to overcome the differentiation cues to convert EpiSCs into cells with naïve pluripotency. </plain></SENT>
<SENT sid="144" pm="."><plain>Our study therefore reveals a new function of Sp5 in mESC self-renewal, which is mediated by CHIR and LIF, and reprogramming of EpiSCs into naïve ESCs. </plain></SENT>
<SENT sid="145" pm="."><plain>In the future, understanding how Sp5 cooperates with other downstream targets of β-catenin and Stat3 to maintain the pluripotent ESC state might facilitate the development of new culture conditions for the derivation of authentic ESCs from various species. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="METHODS"><sec sec-type="methods" id="s3"><title><text><SENT sid="146" pm="."><plain>MATERIALS AND METHODS </plain></SENT>
</text></title><sec id="s3a"><title><text><SENT sid="147" pm="."><plain>Cell culture </plain></SENT>
</text></title><p><text><SENT sid="148" pm="."><plain>46C mESCs, kindly provided by Austin Smith (Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, UK), were cultured on 0.1% gelatin-coated dishes. </plain></SENT>
<SENT sid="149" pm="."><plain>mESC medium contains Glasgow's minimum essential medium (GMEM; Sigma), 10% fetal calf serum (FCS; HyClone), 1% MEM nonessential amino acids (Invitrogen), 2 mM GlutaMax (Invitrogen), 0.1 mM β-mercaptoethanol (Invitrogen) and 100 units/ml LIF (prepared in-house). </plain></SENT>
<SENT sid="150" pm="."><plain>For serum-free culture, mESCs were maintained in N2B27 supplemented with 3 µM CHIR99021 and 1 µM PD0325901 (Sigma), or supplemented with 100 units/ml LIF and 10 ng/ml BMP4 (Peprotech). </plain></SENT>
</text></p></sec><sec id="s3b"><title><text><SENT sid="151" pm="."><plain>Plasmid construction and cell transfection </plain></SENT>
</text></title><p><text><SENT sid="152" pm="."><plain>The coding region of Sp5 was inserted into a PiggyBac vector and transduced into cells combined with 2 µg transposase using LTX (Invitrogen). </plain></SENT>
<SENT sid="153" pm="."><plain>Selection was continued for 1 week by adding 2 µg/ml puromycin. </plain></SENT>
<SENT sid="154" pm="."><plain>The short hairpin RNA (shRNA) plasmids were generated according to the Addgene PLKO.1 protocol. </plain></SENT>
<SENT sid="155" pm="."><plain>The target-specific sequence for Sp5 is 5′-GGATTCAAAGGATTTGCTTTC-3′. </plain></SENT>
</text></p></sec><sec id="s3c"><title><text><SENT sid="156" pm="."><plain>Alkaline phosphatase activity assay and qRT-PCR </plain></SENT>
</text></title><p><text><SENT sid="157" pm="."><plain>The alkaline phosphatase activity assay and qRT-PCR analyses were performed according to our previous report (Ye et al., 2013). </plain></SENT>
<SENT sid="158" pm="."><plain>The primers used for the qRT-PCR analyses are listed in Table S1. </plain></SENT>
</text></p></sec><sec id="s3d"><title><text><SENT sid="159" pm="."><plain>Western blotting </plain></SENT>
</text></title><p><text><SENT sid="160" pm="."><plain>Western blotting was performed according to a standard protocol. </plain></SENT>
<SENT sid="161" pm="."><plain>The primary antibodies used for probing were against α-tubulin (32-2500, Invitrogen; 1:2000), phosphorylated Stat3Y705 (9131S, Cell Signaling Technology; 1:1000), Stat3 (610190, BD Biosciences; 1:1000), phosphorylated β-CateninSer33/Ser37/Thr41 (9561S, Cell Signaling Technology; 1:1000) and β-catenin (610153, BD Biosciences; 1:1000). </plain></SENT>
</text></p></sec><sec id="s3e"><title><text><SENT sid="162" pm="."><plain>Immunofluorescence staining </plain></SENT>
</text></title><p><text><SENT sid="163" pm="."><plain>Immunostaining was performed with standard protocols. </plain></SENT>
<SENT sid="164" pm="."><plain>Primary antibodies used were against Oct4 (sc-5279, Santa Cruz Biotechnology; 1:200), Nanog (AF2729, R&amp;D; 1:100), Klf4 (AF3158, R&amp;D; 1:100), nestin (2Q178, Santa Cruz Biotechnology, 1:100), GATA4 (G4, Santa Cruz Biotechnology, 1:100) and myosin (MF-20, Developmental Studies Hybridoma Bank, 1:50). </plain></SENT>
</text></p></sec><sec id="s3f"><title><text><SENT sid="165" pm="."><plain>mEpiSC derivation and reprogramming </plain></SENT>
</text></title><p><text><SENT sid="166" pm="."><plain>For ESC-to-EpiSC differentiation, 5000 46C mESCs were plated into 0.1% gelatin-coated plates and cultured in serum medium supplemented with activin A (10 ng/ml, Peprotech), bFGF (10 ng/ml, Peprotech) and JW55 (20 µm, Tocris). </plain></SENT>
<SENT sid="167" pm="."><plain>Cells were used after 10 passages. </plain></SENT>
<SENT sid="168" pm="."><plain>For reprogramming, 106 transfectants were seeded onto a 3.5-cm dish and cultured in mESC medium supplemented with LIF and 2i. </plain></SENT>
<SENT sid="169" pm="."><plain>The number of alkaline-phosphatase-positive clones was counted under a microscope. </plain></SENT>
<SENT sid="170" pm="."><plain>ESC-like clones were picked and subsequently expanded in medium containing LIF and serum. </plain></SENT>
</text></p></sec><sec id="s3g"><title><text><SENT sid="171" pm="."><plain>Accession numbers </plain></SENT>
</text></title><p><text><SENT sid="172" pm="."><plain>Data and details of the method for the DNA microarray analysis are available in the Gene Expression Omnibus under accession number GSE50393. </plain></SENT>
</text></p></sec><sec id="s3h"><title><text><SENT sid="173" pm="."><plain>Statistical analysis </plain></SENT>
</text></title><p><text><SENT sid="174" pm="."><plain>All data are reported as the mean±s.d. </plain></SENT>
<SENT sid="175" pm="."><plain>A Student's t-test was used to determine the significance of differences in comparisons. </plain></SENT>
<SENT sid="176" pm="."><plain>Values of P&lt;0.05 were considered as statistically significant. </plain></SENT>
</text></p></sec></sec></SecTag></body><back><SecTag type="ACK_FUND"><ack><title>Acknowledgements</title><p><text4fund><text><SENT sid="177" pm="."><plain>We thank all members of the Ying laboratory for technical assistance, Edward Trope for critical reading of this manuscript, and Bradley J. Merrill (Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago, IL) and Hans R. Schöler (Department of Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Germany) for providing Tcf3-null mESCs and Oct4–GFP EpiSCs, respectively. </plain></SENT>
</text></text4fund></p></ack></SecTag><fn-group><title>Footnotes</title><fn fn-type="conflict"><p><text><SENT sid="180" pm="."><plain>Competing interests </plain></SENT>
</text></p><p><text><SENT sid="181" pm="."><plain>The authors declare no competing or financial interests. </plain></SENT>
</text></p></fn><fn><p><text><SENT sid="182" pm="."><plain>Author contributions </plain></SENT>
</text></p><p><text><SENT sid="183" pm="."><plain>S.Y., D.Z. and F.C. designed the study and performed the experiments; D.W. and J.M. contributed reagents; F.L., S.H., K.H., Q.B. and D.L. analyzed data; S.Y. and Q.-L.Y. wrote the manuscript. </plain></SENT>
</text></p></fn><fn fn-type="financial-disclosure"><p><text><SENT sid="184" pm="."><plain>Funding </plain></SENT>
</text></p><p><text><SENT sid="185" pm="."><plain>This work was supported by California Institute for Regenerative Medicine (CIRM) New Faculty Award II [grant number RN2-00938]; a CIRM Scientiﬁc Excellence through Exploration and Development (SEED) Grant [grant number RS1-00327]; the 211 Scientific Research Startup Fund of Anhui University [grant numbers 10117700027, 32030081, J10117700060]; the Student Research Training Program of Anhui University [grant number J10118515486]; and the Natural Science Foundation of Anhui province and China [grant numbers 1508085SQC204, 1508085MH189, 31501191]. </plain></SENT>
<SENT sid="186" pm="."><plain>Deposited in PMC for immediate release. </plain></SENT>
</text></p></fn><fn fn-type="supplementary-material"><p><text><SENT sid="187" pm="."><plain>Supplementary information </plain></SENT>
</text></p><p><text><SENT sid="188" pm="."><plain>Supplementary information available online at http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.177675/-/DC1 </plain></SENT>
</text></p></fn></fn-group><SecTag type="REF"><ref-list><title>References</title><ref id="JCS177675C1"><text><SENT sid="189" pm="."><plain>BourillotP.-Y., AksoyI., SchreiberV., WiannyF., SchulzH., HummelO., HubnerN. and SavatierP. (2009). Novel STAT3 target genes exert distinct roles in the inhibition of mesoderm and endoderm differentiation in cooperation with Nanog. Stem Cells 27, 1760-1771. 10.1002/stem.11019544440 </plain></SENT>
</text></ref><ref id="JCS177675C2"><text><SENT sid="190" pm="."><plain>BronsI. </plain></SENT>
<SENT sid="191" pm="."><plain>G. </plain></SENT>
<SENT sid="192" pm="."><plain>M., SmithersL. </plain></SENT>
<SENT sid="193" pm="."><plain>E., TrotterM. </plain></SENT>
<SENT sid="194" pm="."><plain>W. </plain></SENT>
<SENT sid="195" pm="."><plain>B., Rugg-GunnP., SunB., Chuva de Sousa LopesS. </plain></SENT>
<SENT sid="196" pm="."><plain>M., HowlettS. </plain></SENT>
<SENT sid="197" pm="."><plain>K., ClarksonA., Ahrlund-RichterL., PedersenR. </plain></SENT>
<SENT sid="198" pm="."><plain>A.et al. (2007). Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448, 191-195. 10.1038/nature0595017597762 </plain></SENT>
</text></ref><ref id="JCS177675C3"><text><SENT sid="199" pm="."><plain>BurdonT., ChambersI., StraceyC., NiwaH. and SmithA. (1999). Signaling mechanisms regulating self-renewal and differentiation of pluripotent embryonic stem cells. Cells Tissues Organs 165, 131-143. 10.1159/00001669310592385 </plain></SENT>
</text></ref><ref id="JCS177675C4"><text><SENT sid="200" pm="."><plain>CartwrightP., McLeanC., SheppardA., RivettD., JonesK. and DaltonS. (2005). LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development 132, 885-896. 10.1242/dev.0167015673569 </plain></SENT>
</text></ref><ref id="JCS177675C5"><text><SENT sid="201" pm="."><plain>CasanovaE. </plain></SENT>
<SENT sid="202" pm="."><plain>A., ShakhovaO., PatelS. </plain></SENT>
<SENT sid="203" pm="."><plain>S., AsnerI. </plain></SENT>
<SENT sid="204" pm="."><plain>N., PelczarP., WeberF. </plain></SENT>
<SENT sid="205" pm="."><plain>A., GrafU., SommerL., BürkiK. and CinelliP. (2011). Pramel7 mediates LIF/STAT3-dependent self-renewal in embryonic stem cells. Stem Cells 29, 474-485. 10.1002/stem.58821425410 </plain></SENT>
</text></ref><ref id="JCS177675C6"><text><SENT sid="206" pm="."><plain>ChambersI., ColbyD., RobertsonM., NicholsJ., LeeS., TweedieS. and SmithA. (2003). Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113, 643-655. 10.1016/S0092-8674(03)00392-112787505 </plain></SENT>
</text></ref><ref id="JCS177675C7"><text><SENT sid="207" pm="."><plain>DuntyW. </plain></SENT>
<SENT sid="208" pm="."><plain>C.Jr, KennedyM. </plain></SENT>
<SENT sid="209" pm="."><plain>W. </plain></SENT>
<SENT sid="210" pm="."><plain>L., ChalamalasettyR. </plain></SENT>
<SENT sid="211" pm="."><plain>B., CampbellK. and YamaguchiT. </plain></SENT>
<SENT sid="212" pm="."><plain>P. (2014). Transcriptional profiling of Wnt3a mutants identifies Sp transcription factors as essential effectors of the Wnt/beta-catenin pathway in neuromesodermal stem cells. PLoS ONE 9, e87018 10.1371/journal.pone.008701824475213 </plain></SENT>
</text></ref><ref id="JCS177675C8"><text><SENT sid="213" pm="."><plain>el-BaradiT. and PielerT. (1991). Zinc finger proteins: what we know and what we would like to know. Mech. </plain></SENT>
<SENT sid="214" pm="."><plain>Dev. 35, 155-169. 10.1016/0925-4773(91)90015-X1768617 </plain></SENT>
</text></ref><ref id="JCS177675C9"><text><SENT sid="215" pm="."><plain>EmaM., MoriD., NiwaH., HasegawaY., YamanakaY., HitoshiS., MimuraJ., KawabeY.-I., HosoyaT., MoritaM.et al. (2008). Krüppel-like factor 5 is essential for blastocyst development and the normal self-renewal of mouse ESCs. Cell Stem Cell 3, 555-567. 10.1016/j.stem.2008.09.00318983969 </plain></SENT>
</text></ref><ref id="JCS177675C10"><text><SENT sid="216" pm="."><plain>EvansM. </plain></SENT>
<SENT sid="217" pm="."><plain>J. and KaufmanM. </plain></SENT>
<SENT sid="218" pm="."><plain>H. (1981). Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154-156. 10.1038/292154a07242681 </plain></SENT>
</text></ref><ref id="JCS177675C11"><text><SENT sid="219" pm="."><plain>GreberB., WuG., BernemannC., JooJ. </plain></SENT>
<SENT sid="220" pm="."><plain>Y., HanD. </plain></SENT>
<SENT sid="221" pm="."><plain>W., KoK., TapiaN., SabourD., SterneckertJ., TesarP.et al. (2010). Conserved and divergent roles of FGF signaling in mouse epiblast stem cells and human embryonic stem cells. Cell Stem Cell 6, 215-226. 10.1016/j.stem.2010.01.00320207225 </plain></SENT>
</text></ref><ref id="JCS177675C12"><text><SENT sid="222" pm="."><plain>GuoG., YangJ., NicholsJ., HallJ. </plain></SENT>
<SENT sid="223" pm="."><plain>S., EyresI., MansfieldW. and SmithA. (2009). Klf4 reverts developmentally programmed restriction of ground state pluripotency. Development 136, 1063-1069. 10.1242/dev.03095719224983 </plain></SENT>
</text></ref><ref id="JCS177675C13"><text><SENT sid="224" pm="."><plain>HallJ., GuoG., WrayJ., EyresI., NicholsJ., GrotewoldL., MorfopoulouS., HumphreysP., MansfieldW., WalkerR.et al. (2009). Oct4 and LIF/Stat3 additively induce Krüppel factors to sustain embryonic stem cell self-renewal. Cell Stem Cell 5, 597-609. 10.1016/j.stem.2009.11.00319951688 </plain></SENT>
</text></ref><ref id="JCS177675C14"><text><SENT sid="225" pm="."><plain>HiraiH., KarianP. and KikyoN. (2011). Regulation of embryonic stem cell self-renewal and pluripotency by leukaemia inhibitory factor. Biochem. </plain></SENT>
<SENT sid="226" pm="."><plain>J. 438, 11-23. 10.1042/BJ2010215221793804 </plain></SENT>
</text></ref><ref id="JCS177675C15"><text><SENT sid="227" pm="."><plain>HoverterN. </plain></SENT>
<SENT sid="228" pm="."><plain>P., TingJ.-H., SundareshS., BaldiP. and WatermanM. </plain></SENT>
<SENT sid="229" pm="."><plain>L. (2012). A WNT/p21 circuit directed by the C-clamp, a sequence-specific DNA binding domain in TCFs. Mol. </plain></SENT>
<SENT sid="230" pm="."><plain>Cell. </plain></SENT>
<SENT sid="231" pm="."><plain>Biol. 32, 3648-3662. 10.1128/MCB.06769-1122778133 </plain></SENT>
</text></ref><ref id="JCS177675C16"><text><SENT sid="232" pm="."><plain>HuangG., YeS., ZhouX., LiuD. and YingQ.-L. (2015). Molecular basis of embryonic stem cell self-renewal: from signaling pathways to pluripotency network. Cell. </plain></SENT>
<SENT sid="233" pm="."><plain>Mol. </plain></SENT>
<SENT sid="234" pm="."><plain>Life Sci. 72, 1741-1757. 10.1007/s00018-015-1833-225595304 </plain></SENT>
</text></ref><ref id="JCS177675C17"><text><SENT sid="235" pm="."><plain>JiangJ., ChanY.-S., LohY.-H., CaiJ., TongG.-Q., LimC.-A., RobsonP., ZhongS. and NgH.-H. (2008). A core Klf circuitry regulates self-renewal of embryonic stem cells. Nat. </plain></SENT>
<SENT sid="236" pm="."><plain>Cell Biol. 10, 353-360. 10.1038/ncb169818264089 </plain></SENT>
</text></ref><ref id="JCS177675C18"><text><SENT sid="237" pm="."><plain>LyashenkoN., WinterM., MiglioriniD., BiecheleT., MoonR. </plain></SENT>
<SENT sid="238" pm="."><plain>T. and HartmannC. (2011). Differential requirement for the dual functions of beta-catenin in embryonic stem cell self-renewal and germ layer formation. Nat. </plain></SENT>
<SENT sid="239" pm="."><plain>Cell Biol. 13, 753-761. 10.1038/ncb226021685890 </plain></SENT>
</text></ref><ref id="JCS177675C19"><text><SENT sid="240" pm="."><plain>MartelloG., SugimotoT., DiamantiE., JoshiA., HannahR., OhtsukaS., GöttgensB., NiwaH. and SmithA. (2012). Esrrb is a pivotal target of the Gsk3/Tcf3 axis regulating embryonic stem cell self-renewal. Cell Stem Cell 11, 491-504. 10.1016/j.stem.2012.06.00823040478 </plain></SENT>
</text></ref><ref id="JCS177675C20"><text><SENT sid="241" pm="."><plain>MartelloG., BertoneP. and SmithA. (2013). Identification of the missing pluripotency mediator downstream of leukaemia inhibitory factor. EMBO J. 32, 2561-2574. 10.1038/emboj.2013.17723942233 </plain></SENT>
</text></ref><ref id="JCS177675C21"><text><SENT sid="242" pm="."><plain>MartinG. </plain></SENT>
<SENT sid="243" pm="."><plain>R. (1981). Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. </plain></SENT>
<SENT sid="244" pm="."><plain>Natl. </plain></SENT>
<SENT sid="245" pm="."><plain>Acad. </plain></SENT>
<SENT sid="246" pm="."><plain>Sci. </plain></SENT>
<SENT sid="247" pm="."><plain>USA 78, 7634-7638. 10.1073/pnas.78.12.76346950406 </plain></SENT>
</text></ref><ref id="JCS177675C22"><text><SENT sid="248" pm="."><plain>MatsudaT., NakamuraT., NakaoK., AraiT., KatsukiM., HeikeT. and YokotaT. (1999). STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J. 18, 4261-4269. 10.1093/emboj/18.15.426110428964 </plain></SENT>
</text></ref><ref id="JCS177675C23"><text><SENT sid="249" pm="."><plain>NiwaH., BurdonT., ChambersI. and SmithA. (1998). Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev. 12, 2048-2060. 10.1101/gad.12.13.20489649508 </plain></SENT>
</text></ref><ref id="JCS177675C24"><text><SENT sid="250" pm="."><plain>NiwaH., OgawaK., ShimosatoD. and AdachiK. (2009). A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells. Nature 460, 118-122. 10.1038/nature0811319571885 </plain></SENT>
</text></ref><ref id="JCS177675C25"><text><SENT sid="251" pm="."><plain>QiuD., YeS., RuizB., ZhouX., LiuD., ZhangQ. and YingQ.-L. (2015). Klf2 and Tfcp2l1, two Wnt/beta-catenin targets, Act synergistically to induce and maintain naive pluripotency. Stem Cell Rep. 5, 314-322. 10.1016/j.stemcr.2015.07.014 </plain></SENT>
</text></ref><ref id="JCS177675C26"><text><SENT sid="252" pm="."><plain>SmithA. </plain></SENT>
<SENT sid="253" pm="."><plain>G. (2001). Embryo-derived stem cells: of mice and men. Annu. </plain></SENT>
<SENT sid="254" pm="."><plain>Rev. </plain></SENT>
<SENT sid="255" pm="."><plain>Cell Dev. </plain></SENT>
<SENT sid="256" pm="."><plain>Biol. 17, 435-462. 10.1146/annurev.cellbio.17.1.43511687496 </plain></SENT>
</text></ref><ref id="JCS177675C27"><text><SENT sid="257" pm="."><plain>SuskeG., BrufordE. and PhilipsenS. (2005). Mammalian SP/KLF transcription factors: bring in the family. Genomics 85, 551-556. 10.1016/j.ygeno.2005.01.00515820306 </plain></SENT>
</text></ref><ref id="JCS177675C28"><text><SENT sid="258" pm="."><plain>TaiC.-I. and YingQ.-L. (2013). Gbx2, a LIF/Stat3 target, promotes reprogramming to and retention of the pluripotent ground state. J. Cell Sci. 126, 1093-1098. 10.1242/jcs.11827323345404 </plain></SENT>
</text></ref><ref id="JCS177675C29"><text><SENT sid="260" pm="."><plain>TesarP. </plain></SENT>
<SENT sid="261" pm="."><plain>J., ChenowethJ. </plain></SENT>
<SENT sid="262" pm="."><plain>G., BrookF. </plain></SENT>
<SENT sid="263" pm="."><plain>A., DaviesT. </plain></SENT>
<SENT sid="264" pm="."><plain>J., EvansE. </plain></SENT>
<SENT sid="265" pm="."><plain>P., MackD. </plain></SENT>
<SENT sid="266" pm="."><plain>L., GardnerR. </plain></SENT>
<SENT sid="267" pm="."><plain>L. and McKayR. </plain></SENT>
<SENT sid="268" pm="."><plain>D. </plain></SENT>
<SENT sid="269" pm="."><plain>G. (2007). New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448, 196-199. 10.1038/nature0597217597760 </plain></SENT>
</text></ref><ref id="JCS177675C30"><text><SENT sid="270" pm="."><plain>TreichelD., BeckerM.-B. and GrussP. (2001). The novel transcription factor gene Sp5 exhibits a dynamic and highly restricted expression pattern during mouse embryogenesis. Mech. </plain></SENT>
<SENT sid="271" pm="."><plain>Dev. 101, 175-179. 10.1016/S0925-4773(00)00544-X11231070 </plain></SENT>
</text></ref><ref id="JCS177675C31"><text><SENT sid="272" pm="."><plain>van OostenA. </plain></SENT>
<SENT sid="273" pm="."><plain>L., CostaY., SmithA. and SilvaJ. </plain></SENT>
<SENT sid="274" pm="."><plain>C. </plain></SENT>
<SENT sid="275" pm="."><plain>R. (2012). JAK/STAT3 signalling is sufficient and dominant over antagonistic cues for the establishment of naive pluripotency. Nat. </plain></SENT>
<SENT sid="276" pm="."><plain>Commun. 3, 817 10.1038/ncomms182222569365 </plain></SENT>
</text></ref><ref id="JCS177675C32"><text><SENT sid="277" pm="."><plain>WaalerJ., MachonO., von KriesJ. </plain></SENT>
<SENT sid="278" pm="."><plain>P., WilsonS. </plain></SENT>
<SENT sid="279" pm="."><plain>R., LundenesE., WedlichD., GradlD., PaulsenJ. </plain></SENT>
<SENT sid="280" pm="."><plain>E., MachonovaO., DembinskiJ. </plain></SENT>
<SENT sid="281" pm="."><plain>L.et al. (2011). Novel synthetic antagonists of canonical Wnt signaling inhibit colorectal cancer cell growth. Cancer Res. 71, 197-205. 10.1158/0008-5472.CAN-10-128221199802 </plain></SENT>
</text></ref><ref id="JCS177675C33"><text><SENT sid="282" pm="."><plain>WeidingerG., ThorpeC. </plain></SENT>
<SENT sid="283" pm="."><plain>J., Wuennenberg-StapletonK., NgaiJ. and MoonR. </plain></SENT>
<SENT sid="284" pm="."><plain>T. (2005). The Sp1-related transcription factors sp5 and sp5-like act downstream of Wnt/beta-catenin signaling in mesoderm and neuroectoderm patterning. Curr. </plain></SENT>
<SENT sid="285" pm="."><plain>Biol. 15, 489-500. 10.1016/j.cub.2005.01.04115797017 </plain></SENT>
</text></ref><ref id="JCS177675C34"><text><SENT sid="286" pm="."><plain>WilliamsR. </plain></SENT>
<SENT sid="287" pm="."><plain>L., HiltonD. </plain></SENT>
<SENT sid="288" pm="."><plain>J., PeaseS., WillsonT. </plain></SENT>
<SENT sid="289" pm="."><plain>A., StewartC. </plain></SENT>
<SENT sid="290" pm="."><plain>L., GearingD. </plain></SENT>
<SENT sid="291" pm="."><plain>P., WagnerE. </plain></SENT>
<SENT sid="292" pm="."><plain>F., MetcalfD., NicolaN. </plain></SENT>
<SENT sid="293" pm="."><plain>A. and GoughN. </plain></SENT>
<SENT sid="294" pm="."><plain>M. (1988). Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336, 684-687. 10.1038/336684a03143916 </plain></SENT>
</text></ref><ref id="JCS177675C35"><text><SENT sid="295" pm="."><plain>WimmerE. </plain></SENT>
<SENT sid="296" pm="."><plain>A., JäckleH., PfeifleC. and CohenS. </plain></SENT>
<SENT sid="297" pm="."><plain>M. (1993). A Drosophila homologue of human Sp1 is a head-specific segmentation gene. Nature 366, 690-694. 10.1038/366690a08259212 </plain></SENT>
</text></ref><ref id="JCS177675C36"><text><SENT sid="298" pm="."><plain>WrayJ., KalkanT., Gomez-LopezS., EckardtD., CookA., KemlerR. and SmithA. (2011). Inhibition of glycogen synthase kinase-3 alleviates Tcf3 repression of the pluripotency network and increases embryonic stem cell resistance to differentiation. Nat. </plain></SENT>
<SENT sid="299" pm="."><plain>Cell Biol. 13, 838-845. 10.1038/ncb226721685889 </plain></SENT>
</text></ref><ref id="JCS177675C37"><text><SENT sid="300" pm="."><plain>YangJ., van OostenA. </plain></SENT>
<SENT sid="301" pm="."><plain>L., TheunissenT. </plain></SENT>
<SENT sid="302" pm="."><plain>W., GuoG., SilvaJ. </plain></SENT>
<SENT sid="303" pm="."><plain>C. </plain></SENT>
<SENT sid="304" pm="."><plain>R. and SmithA. (2010). Stat3 activation is limiting for reprogramming to ground state pluripotency. Cell Stem Cell 7, 319-328. 10.1016/j.stem.2010.06.02220804969 </plain></SENT>
</text></ref><ref id="JCS177675C38"><text><SENT sid="305" pm="."><plain>YeS., LiP., TongC. and YingQ.-L. (2013). Embryonic stem cell self-renewal pathways converge on the transcription factor Tfcp2l1. EMBO J. 32, 2548-2560. 10.1038/emboj.2013.17523942238 </plain></SENT>
</text></ref><ref id="JCS177675C39"><text><SENT sid="306" pm="."><plain>YeS., LiuD. and YingQ.-L. (2014). Signaling pathways in induced naive pluripotency. Curr. </plain></SENT>
<SENT sid="307" pm="."><plain>Opin. </plain></SENT>
<SENT sid="308" pm="."><plain>Genet. </plain></SENT>
<SENT sid="309" pm="."><plain>Dev. 28, 10-15. 10.1016/j.gde.2014.08.00225173148 </plain></SENT>
</text></ref><ref id="JCS177675C40"><text><SENT sid="310" pm="."><plain>YingQ.-L., NicholsJ., ChambersI. and SmithA. (2003). BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115, 281-292. 10.1016/S0092-8674(03)00847-X14636556 </plain></SENT>
</text></ref><ref id="JCS177675C41"><text><SENT sid="311" pm="."><plain>YingQ.-L., WrayJ., NicholsJ., Batlle-MoreraL., DobleB., WoodgettJ., CohenP. and SmithA. (2008). The ground state of embryonic stem cell self-renewal. Nature 453, 519-523. 10.1038/nature0696818497825 </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
